India on Wednesday suspended the Indus Water Treaty and announced downgrading diplomatic ties with Pakistan including expulsion of its military attaches in view of cross-border links to the Pahalgam terror attack.The CCS decided that the Indus Waters Treaty of 1960 will be held in abeyance with immediate effect, until Pakistan credibly and irrevocably abjures its support for cross-border terrorism, Foreign Secretary Vikram Misri said at a media briefing.The Integrated Check Post at Attari will be closed with immediate effect, he said.Published on April 23, 2025 Those who have crossed over with valid endorsements may return through that route before May 1, he said.The Cabinet Committee on Security (CCS) met this evening under the chairmanship of Prime Minister Narendra Modi and firmed up the responses to the terror attack.

According to Sandeep Sehgal, Partner at AKM Global, the said ruling highlights a crucial distinction between approved healthcare diagnostics and new, tech-driven testing methods. It clearly states that not all laboratory tests are automatically exempt from GST. If a test is still in the experimental stage and lacks approvals from regulatory bodies like ICMR or CDSCO, it will be treated as research and subject to GST. This is a key takeaway for diagnostic start-ups and labs using advanced technologies like genome sequencing or AI-based testing. Therefore, “to qualify for GST exemption under healthcare services, obtaining proper medical licenses and regulatory approvals is essential,” he said.Published on April 21, 2025 “The primary activity is research and experimental development of Cancer Prognostic and Diagnostic Technologies,” MAAR said while ruling that it is not eligible for the benefit of exemption. The quails judicial body observed that diagnostic test is still in its developmental stage and is not yet validated by the medical regulatory bodies. It noticed that applicant has not produced any license or certificate from Central Drugs Standard Control Organisation or any approval from Indian Council for Medical Research . It also said: “Tests cannot be treated as a proper diagnostic test but is more in the nature of clinical research and development and as a result it does not qualify as a Health Care Service.”Epigeneres Biotech Private Ltd had moved MAAR seeking advance ruling on whether the provision of diagnostic services would qualify for exemption from GST. Diagnostic services for conducting blood tests which assists in early detection of cancer fall out of the periphery of ‘Healthcare services’, Maharashtra’s Authority for Advance Ruling (MAAR) has ruled. This means such a service will not be exempted from GST.